These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 9813111
21. The steroid receptor co-activator-1 (SRC-1) potentiates TGF-beta/Smad signaling: role of p300/CBP. Dennler S, Pendaries V, Tacheau C, Costas MA, Mauviel A, Verrecchia F. Oncogene; 2005 Mar 10; 24(11):1936-45. PubMed ID: 15688032 [Abstract] [Full Text] [Related]
22. Regulation of transforming growth factor-beta and bone morphogenetic protein signalling by transcriptional coactivator GCN5. Kahata K, Hayashi M, Asaka M, Hellman U, Kitagawa H, Yanagisawa J, Kato S, Imamura T, Miyazono K. Genes Cells; 2004 Feb 10; 9(2):143-51. PubMed ID: 15009097 [Abstract] [Full Text] [Related]
23. Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3). Long J, Wang G, Matsuura I, He D, Liu F. Proc Natl Acad Sci U S A; 2004 Jan 06; 101(1):99-104. PubMed ID: 14691252 [Abstract] [Full Text] [Related]
24. Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity. Sang N, Avantaggiati ML, Giordano A. J Cell Biochem; 1997 Sep 01; 66(3):277-85. PubMed ID: 9257185 [Abstract] [Full Text] [Related]
25. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response. Pfitzner E, Jähne R, Wissler M, Stoecklin E, Groner B. Mol Endocrinol; 1998 Oct 01; 12(10):1582-93. PubMed ID: 9773981 [Abstract] [Full Text] [Related]
26. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism. Schiller M, Verrecchia F, Mauviel A. Oncogene; 2003 Dec 04; 22(55):8881-90. PubMed ID: 14654784 [Abstract] [Full Text] [Related]
27. Involvement of p300 in TGF-beta/Smad-pathway-mediated alpha2(I) collagen expression in mouse mesangial cells. Kanamaru Y, Nakao A, Tanaka Y, Inagaki Y, Ushio H, Shirato I, Horikoshi S, Okumura K, Ogawa H, Tomino Y. Nephron Exp Nephrol; 2003 Dec 04; 95(1):e36-42. PubMed ID: 14520013 [Abstract] [Full Text] [Related]
35. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling. Suh N, Roberts AB, Birkey Reffey S, Miyazono K, Itoh S, ten Dijke P, Heiss EH, Place AE, Risingsong R, Williams CR, Honda T, Gribble GW, Sporn MB. Cancer Res; 2003 Mar 15; 63(6):1371-6. PubMed ID: 12649201 [Abstract] [Full Text] [Related]
36. BF-1 interferes with transforming growth factor beta signaling by associating with Smad partners. Dou C, Lee J, Liu B, Liu F, Massague J, Xuan S, Lai E. Mol Cell Biol; 2000 Sep 15; 20(17):6201-11. PubMed ID: 10938097 [Abstract] [Full Text] [Related]
37. Smad2 and 3 mediate transforming growth factor-beta1-induced inhibition of chondrocyte maturation. Ferguson CM, Schwarz EM, Reynolds PR, Puzas JE, Rosier RN, O'Keefe RJ. Endocrinology; 2000 Dec 15; 141(12):4728-35. PubMed ID: 11108288 [Abstract] [Full Text] [Related]